ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP), in collaboration with the World Health Organization (WHO), held a two-day national workshop aimed at strengthening the licensing of establishments and Good Storage and Distribution Practices (GSDP) in the country.
The workshop was conducted under the WHO Global Benchmarking Tool (GBT) on October 28-29, 2026, in Islamabad.
Federal and provincial regulatory representatives attended the session, which focused on regulatory harmonisation, risk-based inspections, GSDP compliance, identification of regulatory gaps, and preparation of time-bound action plans.
The discussions were aimed at supporting a more coordinated, harmonised and robust regulatory framework for Pakistan’s regulatory system.
